Dr. Michal Krauze
Overview
Michal Krauze, MD, PhD, is a medical oncologist at UPMC Hillman Cancer Center. He has a special interest in breast cancer, colon cancer, gastrointestinal oncology, thoracic oncology, lung cancer, genitourinary oncology, prostate cancer, and malignant hematology.
Dr. Krauze is highly rated in 14 conditions, according to our data. His top areas of expertise are Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.
His clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
800 Howard Avenue, Suite 1, Altoona, PA 16601
200 Village Drive, Greensburg, PA 15601
1000 Bower Hill Road, Suite 7700, Pittsburgh, PA 15243
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UPMC Hillman Cancer Center At UPMC Altoona
Mark Keating, MD, is a medical oncologist specializing in tumors and diseases of the blood. He has a particular expertise in the diagnosis and treatment of gastrointestinal, kidney, bladder, breast, lung, head and neck, and prostate cancers, as well as chronic leukemia, lymphoma, brain tumors, and benign hematologic disorders. Dr. Keating is highly rated in 72 conditions, according to our data. His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Paget Disease of the Breast, and Non-Hodgkin Lymphoma.
UPMC Hillman Cancer Center At John P. Murtha Pavilion
Ibrahim Sbeitan, MD, specializes in hematology oncology and is board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. He practices at UPMC Hillman Cancer Center. Dr. Sbeitan received his medical degree from the University of Jordan School of Medicine and completed his residency at Gundersen Medical Foundation in La Crosse, Wisconsin, followed by a fellowship at the University of Pittsburgh School of Medicine. Dr. Sbeitan is highly rated in 50 conditions, according to our data. His top areas of expertise are Chronic Familial Neutropenia, Familial Colorectal Cancer, Colorectal Cancer, and Lynch Syndrome.
UPMC Hillman Cancer Center At UPMC Altoona
Louann Zhang, MD, is a medical oncologist specializing in all medical oncology and hematology cases. Dr. Zhang is highly rated in 14 conditions, according to our data. Her top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Paget Disease of the Breast, and Inflammatory Breast Cancer.
Frequently Asked Questions about Dr. Michal Krauze
How do I make an appointment with Dr. Michal Krauze?
You can book an appointment with Dr. Michal Krauze by calling their office at 582-822-4281. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Michal Krauze a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michal Krauze is classified as an Distinguished expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Michal Krauze specialize in?
While Dr. Michal Krauze is a Hematology Oncology, they have specific expertise in Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Michal Krauze participate in research or clinical trials?
Yes. Dr. Michal Krauze has published 6 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Dr. Michal Krauze's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Michal Krauze accept my insurance?
Dr. Michal Krauze accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 582-822-4281 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Krauze isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Lung AdenocarcinomaDr. Krauze isDistinguished. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Krauze isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Krauze isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Krauze isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- AnemiaDr. Krauze isAdvanced. Learn about Anemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Krauze isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- EGFR Positive Lung CancerDr. Krauze isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Krauze isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung CancerDr. Krauze isAdvanced. Learn about Lung Cancer.
- Experienced
- Adult Immune ThrombocytopeniaDr. Krauze isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Krauze isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Krauze isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Krauze isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Krauze isExperienced. Learn about Angiosarcoma.
- Antiphospholipid SyndromeDr. Krauze isExperienced. Learn about Antiphospholipid Syndrome.